Is ESGCT up or down today?
ESGCT is flat 0.02% today, last at 192.45. This stock moved -0.02% versus the prior close.
ESGCT · ESGCT
ESGCT (ESGCT) is trading at 192.45, flat 0.02% on the session. ESGCT sits at the 50% mark of its 52-week range.
Leading the coverage: “CPTx to present new in vivo data for its in vivo CAR T cell therapies at ESGCT 2026 - Yahoo Finance UK” (Google News Earnings, 7d ago). ESGCT is -0.51% since story.
ESGCT trades on a trailing P/E of 37.9.
Analyst firms are mostly reiterating — no strong directional shift lately.
ESGCT is flat 0.02% today, last at 192.45. This stock moved -0.02% versus the prior close.
Leading the coverage: “CPTx to present new in vivo data for its in vivo CAR T cell therapies at ESGCT 2026 - Yahoo Finance UK” (Google News Earnings, 7d ago). ESGCT is -0.51% since story. Dominant story: Addition Therapeutics to Present Preclinical Data from PRINT™ Programs at the European Society of Gene & Cell Therapy’s (ESGCT) 33rd Annual Congress - The Manila Times (1 source, neutral) RSI unavailable Price sits at 50% of its 52-week range Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Historical price chart unavailable
Live quote in the header is real, but OHLC history could not be loaded from Yahoo Finance or fallback providers. Charts use Yahoo when configured correctly — check server logs for provider errors.
Addition Therapeutics to Present Preclinical Data from PRINT™ Programs at the European Society of Gene & Cell Therapy’s (ESGCT) 33rd Annual Congress - The Manila Times
ESGCT in focus ahead of earnings next week
ESGCT volatility spikes as options activity jumps
AskBio Announces 5 Presentations at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress - Yahoo Finance
CPTx to present new in vivo data for its in vivo CAR T cell therapies at ESGCT 2026 - Yahoo Finance UK